Wordt geladen...
The proto-oncogene Mer tyrosine kinase is a novel therapeutic target in mantle cell lymphoma
BACKGROUND: Mantle cell lymphoma (MCL) is an incurable B cell-derived malignant tumor with a median overall survival of 4–5 years. Mer tyrosine kinase (MerTK) has been reported to be aberrantly expressed in leukemia, melanoma, and gastric cancer, and plays a pivotal role in the process of oncogenesi...
Bewaard in:
| Gepubliceerd in: | J Hematol Oncol |
|---|---|
| Hoofdauteurs: | , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BioMed Central
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5859520/ https://ncbi.nlm.nih.gov/pubmed/29554921 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-018-0584-6 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|